Esperion Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $362k | 121k | 2.99 |
| 2023-09-30 | $87k | 89k | 0.98 |
| 2023-06-30 | $144k | 104k | 1.39 |
| 2023-03-31 | $255k | 160k | 1.59 |
| 2022-12-31 | $1.0M | 163k | 6.24 |
| 2022-09-30 | $280k | 42k | 6.72 |
| 2022-06-30 | $178k | 28k | 6.34 |
| 2022-03-31 | $163k | 35k | 4.64 |
| 2021-12-31 | $480k | 96k | 5.02 |
| 2021-09-30 | $585k | 49k | 12.04 |
| 2021-06-30 | $726k | 34k | 21.16 |
| 2021-03-31 | $1.1M | 38k | 28.04 |
| 2020-12-31 | $1.4M | 56k | 26.00 |
| 2020-09-30 | $441k | 12k | 37.18 |
| 2020-06-30 | $9.5M | 185k | 51.31 |
| 2020-03-31 | $5.7M | 179k | 31.53 |
| 2019-12-31 | $8.2M | 137k | 59.63 |
| 2019-09-30 | $1.3M | 35k | 36.70 |
| 2019-06-30 | $2.0M | 43k | 46.51 |
| 2019-03-31 | $660k | 16k | 40.23 |
| 2018-12-31 | $931k | 20k | 46.09 |
| 2018-09-30 | $2.8M | 63k | 44.42 |
| 2018-06-30 | $1.2M | 31k | 39.43 |
| 2018-03-31 | $3.9M | 54k | 72.32 |
| 2017-12-31 | $4.6M | 71k | 65.67 |
| 2017-09-30 | $377k | 7.5k | 50.03 |
| 2017-06-30 | $13M | 155k | 83.33 |
| 2017-03-31 | $774k | 22k | 35.38 |
| 2016-12-31 | $202k | 16k | 12.51 |
| 2016-09-30 | $3.1k | 274 | 11.24 |
| 2016-06-30 | $3.5k | 388 | 8.98 |
| 2016-03-31 | $3.4k | 188 | 18.18 |
| 2015-12-31 | $37k | 1.7k | 22.18 |
| 2015-09-30 | $904k | 39k | 22.96 |
| 2015-06-30 | $1.4M | 17k | 81.04 |
| 2015-03-31 | $1.9M | 21k | 92.00 |
| 2014-12-31 | $35k | 902 | 38.83 |
| 2014-09-30 | $32k | 1.7k | 19.42 |
| 2014-06-30 | $53k | 3.5k | 15.03 |
| 2014-03-31 | $40k | 2.7k | 14.64 |
| 2013-12-31 | $999 | 102 | 9.80 |
| 2013-09-30 | $7.0k | 350 | 20.00 |